ENCELIMAB
UNII N151VZIIPD

Substance Identification & Data

This profile provides standardized clinical and technical data for Encelimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) N151VZIIPD.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2173096-82-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
N151VZIIPD
CAS Registry Number
2173096-82-5
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
ENCELIMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C142978
National Cancer Institute reference terminology for clinical and research data.
INN ID
11056
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Encelimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ENCELIMAB

Common Names & Synonyms

ENCELIMAB [INN]
ENCELIMAB [WHO-DD]
IMMUNOGLOBULIN G4 (222-PROLINE), ANTI-(HUMAN LYMPHOCYTE ACTIVATION GENE-3 PROTEIN) (HUMAN-MUS MUSCULUS MONOCLONAL WBP220C .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL WBP220C .KAPPA.-CHAIN, DIMER

Technical Codes

WBP220C
WBP-220C

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus